DE HB329 | 2019-2020 | 150th General Assembly

Status

Spectrum: Moderate Partisan Bill (Democrat 9-1)
Status: Introduced on April 17 2020 - 25% progression
Action: 2020-04-17 - Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House
Pending: House Economic Development/Banking/Insurance & Commerce Committee
Text: Latest bill text (Draft #1) [HTML]

Summary

Individuals who are at very high risk of getting HIV can take pre-exposure prophylaxis (PrEP) medication to reduce the risk of HIV transmission. PrEP medication reduces the risk of HIV transmission by up to 99% if taken daily. This Act prohibits discrimination because an individual takes PrEP medication in the issuance or renewal of disability, long-term care, and life insurance.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

An Act To Amend Title 18 Of The Delaware Code Relating To Insurance Discrimination Based On Pre-exposure Prophylaxis Medication To Prevent Hiv Infection.

Sponsors


History

DateChamberAction
2020-04-17 Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House

Delaware State Sources


Bill Comments

feedback